Immunoregulatory receptors are categorized as stimulatory or inhibitory based on their engagement of unique intracellular signaling networks. These proteins also display functional plasticity, which adds versatility to the control of innate immunity. Here we demonstrate that an inhibitory catfish leukocyte immune-type receptor (IpLITR) also displays stimulatory capabilities in a representative myeloid cell model. Previously, the receptor IpLITR 1.1b was shown to inhibit natural killer cell-mediated cytotoxicity. Here we expressed IpLITR 1.1b in rat basophilic leukemia-2H3 cells and monitored intracellular signaling and functional responses. Although IpLITR 1.1b did not stimulate cytokine secretion, activation of this receptor unexpectedly induced phagocytosis as well as extracellular signal-related kinase 1/2- and protein kinase B (Akt)-dependent signal transduction. This novel IpLITR 1.1b-mediated response was independent of an association with the FcRγ chain and was likely due to phosphotyrosine-dependent adaptors associating with prototypical signaling motifs within the distal region of its cytoplasmic tail. Furthermore, compared to a stimulatory IpLITR, IpLITR 1.1b displayed temporal differences in the induction of intracellular signaling, and IpLITR 1.1b-mediated phagocytosis had reduced sensitivity to EDTA and cytochalasin D. Overall, this is the first demonstration of functional plasticity for teleost LITRs, a process likely important for the fine-tuning of conserved innate defenses.

Keywords:
Phagocytosis, Intracellular signaling, Phosphorylation , Immunoregulatory receptors, Kinases, Phosphatases , Leukocyte immune-type receptors, Teleost, Channel catfish, Comparative immunology
1.
Steevels TAM, Meyaard L: Immune inhibitory receptors: essential regulators of phagocyte function. Eur J Immunol 2011;41:575-587.
2.
Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008;9:495-502.
3.
Takai T: Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 2005;25:1-18.
4.
Barclay AN: Membrane proteins with immunoglobulin-like domains - a master superfamily of interaction molecules. Semin Immunol 2003;14:215-223.
5.
Weis WI, Taylor ME, Drickamer K: The C-type lectin superfamily in the immune system. Immunol Rev 1998;163:19-34.
6.
Barrow AD, Trowsdale J: The extended leukocyte receptor complex: diverse ways of modulating immune responses. Immunol Rev 2008;224:98-123.
7.
Vivier E, Daeron M: Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997;18:286-291.
8.
Ravetch JV, Lanier LL: Immune inhibitory receptors. Science 2000;90:84-89.
9.
Long EO: Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
10.
Feng J, Call ME, Wucherpfennig KW: The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site. PLoS Biol 2006;4:e142.
11.
Humphrey MB, Lanier LL, Nakamura MC: Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev 2005;208:50-65.
12.
Abram CL, Lowell CA: The expanding role for ITAM-based signaling pathways in immune cells. Sci STKE 2007;377:re2.
13.
Bezbradica JS, Medzhitov R: Role of ITAM signaling module in signal integration. Curr Opin Immunol 2012;24:58-66.
14.
Underhill DM, Goodridge HS: The many faces of ITAMs. Trends Immunol 2007;28:66-73.
15.
Blank U, Launay P, Benhamou M, Monteiro RC: Inhibitory ITAMs as novel regulators of immunity. Immunol Rev 2009;232:59-71.
16.
Àlvarez-Errico D, Sayós J, López-Botet N: The IREM-1 (CD300f) inhibitory receptor associates with the p85 α subunit of phosphoinositide 3-kinase. J Immunol 2007;178:808-816.
17.
Izawa K, Kitaura J, Yamanishi Y, Matsuoka T, Kaitani A, Sugiuchi M, Takahashi M, Maehara A, Enomoto Y, Oki T, Takai T, Kitamura T: An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRγ in mast cells. J Immunol 2009;183:925-936.
18.
Newman PJ, Newman DK: Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003;23:953-964.
19.
Faure M, Long EO: KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 2002;168:6208-6214.
20.
Rajagopalan S, Fu J, Long EO: Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD185d) in resting NK cells. J Immunol 2001;167:1877-1881.
21.
Yusa S, Catina TL, Campbell KS: SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol 2002;168:5047-5057.
22.
Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS: KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 2003;171:3415-3425.
23.
Kikuchi-Maki A, Catina TL, Campbell KS: Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J Immunol 2005;174:3859-3863.
24.
Koncz G, Pecht I, Gergely J, Sármay G: Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase. Eur J Immunol 1999;29:1980-1989.
25.
Takai T: Role of Fc receptors in autoimmunity. Nat Rev Immunol 2002;2:580-592.
26.
Joiner KA, Fuhrman SA, Miettinen HM, Kasper LH, Mellman I: Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science 1990;249:641-646.
27.
Zhang Y, Zhou Y, Yang Q, Mu C, Duan E, Chen J, Yang M, Xia P, Cui B: Ligation of Fc gamma receptor IIB enhances levels of antiviral cytokine in response to PRRSV infection in vitro. Vet Microbiol 2012;160:473-480.
28.
Stafford JL, Bengtén E, Du Pasquier L, McIntosh RD, Quiniou SM, Clem LW, Miller NW, Wilson M: A novel family of diversified immunoregulatory receptors in teleosts is homologous to both mammalian Fc receptors and molecules encoded within the leukocyte receptor complex. Immunogenetics 2006;58:758-773.
29.
Stafford JL, Bengtén E, Du Pasquier L, Miller NW, Wilson M: Channel catfish leukocyte immune-type receptors contain a putative MHC class I binding site. Immunogenetics 2007;59:77-91.
30.
Montgomery BC, Cortes HD, Mewes-Ares J, Verheijen K, Stafford JL: Teleost IgSF immunoregulatory receptors. Dev Comp Immunol 2011;35:1223-1237.
31.
Montgomery BC, Mewes J, Davidson C, Burshtyn DN, Stafford JL: Cell surface expression of channel catfish leukocyte immune-type receptors (IpLITRs) and recruitment of both Src homology 2 domain-containing protein tyrosine phosphatase (SHP)-1 and SHP-2. Dev Comp Immunol 2009;33:570-582.
32.
Mewes J, Verheijen K, Montgomery BC, Stafford JL: Stimulatory catfish leukocyte immune-type receptors (IpLITRs) demonstrate a unique ability to associate with adaptor signaling proteins and participate in the formation of homo- and heterodimers. Mol Immunol 2009;47:318-331.
33.
Cortes HD, Montgomery BC, Verheijen K, García-García E, Stafford JL: Examination of the stimulatory signaling potential of a channel catfish leukocyte immune-type receptor and associated adaptor. Dev Comp Immunol 2012;36:62-73.
34.
Montgomery BC, Cortes HD, Burshtyn DN, Stafford JL: Channel catfish leukocyte immune-type receptor mediated inhibition of cellular cytotoxicity is facilitated by SHP-1-dependent and -independent mechanisms. Dev Comp Immunol 2012;37:151-163.
35.
Heuser JE, Anderson RG: Hypertonic media inhibit receptor-mediated endocytosis by blocking clatherin-coated pit formation. J Cell Biol 1989;108:389-400.
36.
Kozik P, Francis RW, Seaman MNJ, Robinson MS: A screen for endocytic motifs. Traffic 2010;11:843-855.
37.
Janes PW, Ley SC, Magee AI: Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 1999;147:447-461.
38.
Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
39.
Baumruker T, Prieschl EE: Sphingolipids and the regulation of the immune response. Semin Immunol 2002;14:57-63.
40.
Yoshizaki F, Nakayama H, Iwahara C, Takamori K, Ogawa H, Iwabuchi K: Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. Biochim Biophys Acta 2008;1780:383-392.
41.
Garcia-Garcia E, Grayfer L, Stafford JL, Belosevic M: Evidence for the presence of functional lipid rafts in immune cells of ectothermic organisms. Dev Comp Immunol 2012;37:257-269.
42.
Gronski MA, Kinchen JM, Juncadella IJ, Franc NC, Ravichandran KS: An essential role for calcium flux in phagocytes for apoptotic cell engulfment and the α-inflammatory response. Cell Death Differ 2009;10:1323-1331.
43.
Hishikawa T, Cheung JY, Yelamarty RV, Knutson DW: Calcium transients during Fc receptor-mediated and nonspecific phagocytosis by murine peritoneal macrophages. J Cell Biol 1991;115:59-66.
44.
Rosales C, Brown EJ: Two mechanisms for IgG Fc-receptor-mediated phagocytosis by human neutrophils. J Immunol 1991;146:3937-3944.
45.
Altrichter J, Guse AH, Resch K, Brock J, Daëron M, Hückel C: Phosphatidylinositol hydrolysis and an increase in Ca2+ concentration in the signal-transduction process triggered by murine FcγRIII are not required for protein kinase C translocation. Eur J Biochem 1994;228:587-595.
46.
Lennartz MR, Lefkowith JB, Bromley FA, Brown EJ: Immunoglobulin G-mediated phagocytosis activates a calcium-independent, phosphatidylethanolamine-specific phospholipase. J Leukoc Biol 1993;54:389-398.
47.
Groves E, Dart AE, Covarelli V, Caron E: Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol Life Sci 2008;65:1957-1976.
48.
Castellano F, Montcourrier P, Chavrier P: Membrane recruitment of Rac1 triggers phagocytosis. J Cell Sci 2000;113:2955-2961.
49.
Yoder JA, Orcutt TM, Traver D, Litman GW: Structural characteristics of zebrafish orthologs of adaptor molecules that associate with transmembrane immune receptors. Gene 2007;401:154-164.
50.
Tomasello E, Cant Charles, Bühring H-J, Vély F, André P, Seiffert M, Ullrich A, Vivier E: Association of signal-regulatory proteins β with KARAP/DAP12. Eur J Immunol 2000;30:2147-2156.
51.
Anfossi N, Lucas M, Diefenbach A, Bühring H-J, Raulet D, Tomasello E, Vivier E: Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Eur J Immunol 2003;33:3514-3522.
52.
Schleinitz N, Chiche L, Guia S, Bouvier G, Vernier J, Morice A, Houssaint E, Harlé JR, Kaplanski G, Montero-Julian FA, Vély F: Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients. PLoS One 2009;4:e6264.
53.
Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL: SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 2004;173:945-954.
54.
Shlapatska LM, Mikhalap SV, Berdova AG, Zelensky OM, Yun TJ, Nichols KE, Clark EA, Sidorenko SP: CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol 2001;166:5480-5487.
55.
Mikhalap SV, Shlapatska LM, Berdova AG, Law CL, Clark EA, Sidorenko SP: CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD96-mediated apoptosis. J Immunol 1999;15:5719-5727.
56.
Aoukaty A, Tan R: Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J Biol Chem 2002;277:13331-13337.
57.
Sidorenko SP, Clark EA: The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003;4:19-24.
58.
Li C, Iosef C, Jia CY, Han VK, Li SS: Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors. J Biol Chem 1993;278:3852-3859.
59.
Brummer T, Schmitz-Peiffer C, Daly RJ: Docking proteins. FEBS J 2010;277:4356-4369.
60.
Li W, Nishimura R, Kashishian A, Batzer AG, Kim WJ, Cooper JA, Schlessinger J: A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol Cell Biol 1994;12:509-517.
61.
Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG: Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras. Proc Natl Acad Sci USA 1991;91:7335-7339.
62.
Belov AA, Mohammadi N: Grb2, a double-edged sword of receptor tyrosine kinase signaling. Sci Signal 2012;5:pe49.
63.
Gu H, Pratt JC, Burakoff SJ, Neel BG: Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell 1998;2:729-740.
64.
Qu C-K: Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response. Biochim Biophys Acta 2002;1592:297-301.
65.
Liu Y, Jenkins B, Shin JL, Rohrschneider LR: Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptors tyrosine kinase. Mol Cell Biol 2001;21:3047-3056.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.